COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 89: Articles 881-890  | Next

Impact of the COVID-19 pandemic on the uptake of intermittent sulphadoxine-pyrimethamine for prevention of malaria amongst pregnant women in Sierra Leone
Pessima, W. T., Molleh, B., Sillah-Kanu, M., Stafford, B., Lahai, W. K., Falama, A. M., Mishra, S., Chan, A. K., Sevalie, S., Lakoh, S., Lahai, M.
10.1101/2025.01.21.25320891 — Posted: 2025-01-22
De novo design of epitope-specific antibodies against soluble and multipass membrane proteins with high specificity, developability, and function
Nabla Bio, , Biswas, S.
10.1101/2025.01.21.633066 — Posted: 2025-01-22
Evidence suggests that the SARS-CoV-2 Spike (S) protein may target coiled-coil regions of numerous cytoskeletal and cytoskeleton-associated proteins
Brezellec, P.
10.1101/2025.01.20.633897 — Posted: 2025-01-21
Tryptophan metabolism reprogramming contributes to the prothrombotic milieu in mice and humans infected with SARS-CoV-2
Subramaniam, S., Napoleon, M. A., Lotfollahzadeh, S., Kamal, M. H., Kurniawan, H., Elsadawi, M., Kenney, D., Dhouam, F., Bosmann, M., Whelan, S., Cabral, H., Burks, E. J., Zhao, G., Kolachalama, V., Ravid, K., Chitalia, V.
10.1101/2025.01.17.633602 — Posted: 2025-01-21
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination
Purcell, R. A., Aurelia, L. C., Allen, L. F., Bond, K. A., Williamson, D. A., Trevillyan, J. M., Trubiano, J. A., Wines, B. D., Hogarth, P. M., Juno, J. A., Wheatley, A. K., Nguyen, T. H., Subbarao, K., Kedzierska, K., Kent, S. J., Mahanty, S., John Selva, K., Chung, A. W.
10.1101/2025.01.20.25320822 — Posted: 2025-01-20
A phylogenetic method identifies candidate drivers of the evolution of the SARS-CoV-2 mutation spectrum
Corbett-Detig, R.
10.1101/2025.01.17.633662 — Posted: 2025-01-20
GALILEO Generatively Expands Chemical Space and Achieves One-Shot Identification of a Library of Novel, Specific, Next Generation Broad-Spectrum Antiviral Compounds at High Hit Rates
Umansky, T., Woods, V., Russell, S. M., Garvey, D. S., Smith, D. M., Haders, D.
10.1101/2025.01.17.633620 — Posted: 2025-01-20
Modular DNA Barcoding of Nanobodies Enables Multiplexed in situ Protein Imaging and High-throughput Biomolecule Detection
Zhong, S., Wang, R., Gao, X., Guo, Q., Lin, R., Luo, M.
10.1101/2025.01.16.633477 — Posted: 2025-01-20
Optimizing Transfection Efficiency in Primary Human Splenic Fibroblast Cells
Kaur, A., Assogba, V. I., Assogba, B. D.
10.1101/2025.01.19.633792 — Posted: 2025-01-20
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals
Dadonaite, B., Burrell, A. R., Logue, J., Chu, H. Y., Payne, D. C., Haslam, D. B., Staat, M. A., Bloom, J. D.
10.1101/2025.01.17.633612 — Posted: 2025-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).